iSpecimen (ISPC) Free Cash Flow Growth (1y) (2021 - 2026)
iSpecimen (ISPC) Free Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 51.58% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 16.06% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 112.68% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 87.85% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 23.29% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -20.33% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -21.08% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 33.01% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 5.28% |
| 10 | iSpecimen | 658,857.59 | -2.16 Mn | 71,599.00 | -270.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -270.66% |
| Dec 31, 2025 | 102.31% |
| Sep 30, 2025 | -363.09% |
| Jun 30, 2025 | 90.28% |
| Mar 31, 2025 | 47.35% |
| Dec 31, 2024 | -1,137.42% |
| Sep 30, 2024 | -160.78% |
| Jun 30, 2024 | 31.45% |
| Mar 31, 2024 | 52.32% |
| Dec 31, 2023 | -69.36% |
| Sep 30, 2023 | 135.60% |
| Jun 30, 2023 | -19.42% |
| Mar 31, 2023 | -154.51% |
| Dec 31, 2022 | 290.57% |
| Sep 30, 2022 | 55.52% |
| Jun 30, 2022 | 17.55% |
| Mar 31, 2022 | -403.28% |
| Dec 31, 2021 | -2,355.50% |
| Sep 30, 2021 | -2,616.16% |